+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Geriatric Care Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Mobility Assistance Aids , Assistive Furniture , Bathroom Safety & Assistive Products , Monitoring & Tracking Devices , Communication Aids ), By Application (Fall Prevention & Mobility, Chronic Disease Management, Daily Living Assistance, Safety & Security Monitoring), By End-User (Hospitals & Specialty Clinics, Elderly Nursing Homes, Assisted Living Facilities, Homecare Settings) Companies, and Country Forecast, 2021 to 2034

Global Geriatric Care Devices Market size is forecast to increase from $1.38 Billion in 2026 to $2.27 Billion in 2034 at a CAGR of 6.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007357
Pages: 224 Pages

Genotyping Market Size, Share and Growth Outlook, 2026: Analysis By Product & Service (Reagents & Kits, Instruments, Software & Services), By Technology (PCR-based Genotyping, Microarray-based Genotyping, Sequencing-based Genotyping, Mass Spectrometry-based Genotyping), By Application (Pharmacogenomics, Diagnostics & Personalized Medicine, Agricultural Biotechnology, Animal Genetics), By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Genotyping Market size is forecast to increase from $10.56 Billion in 2026 to $29.7 Billion in 2034 at a CAGR of 13.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007356
Pages: 218 Pages

Genotyping Assay Market Size, Share and Growth Outlook, 2026: Analysis By Product & Service (Reagents & Kits, Instruments, Software & Bioinformatics, Services), By Technology (Polymerase Chain Reaction , Microarrays, Sequencing, Capillary Electrophoresis, Mass Spectrometry), By Application (Pharmacogenomics, Diagnostics & Personalized Medicine, Agricultural Biotechnology, Animal Genetics), By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Genotyping Assay Market size is forecast to increase from $23.08 Billion in 2026 to $68.18 Billion in 2034 at a CAGR of 14.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007355
Pages: 215 Pages

Genomics Market Size, Share and Growth Outlook, 2026: Analysis By Product & Service (Instruments & Systems, Consumables & Reagents, Software & Informatics, Services), By Technology (Sequencing, Polymerase Chain Reaction , Microarray, Nucleic Acid Extraction & Purification, Other Techniques), By Application (Diagnostics, Drug Discovery & Development, Precision Medicine, Agriculture & Animal Genomics, Forensics & Ancestry), By End User (Hospitals & Clinics, Diagnostic & Reference Laboratories, Research Institutes & Academic Centers, Pharmaceutical & Biotechnology Companies) Companies, and Country Forecast, 2021 to 2034

Global Genomics Market size is forecast to increase from $46.78 Billion in 2026 to $126.13 Billion in 2034 at a CAGR of 13.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007354
Pages: 210 Pages

Genomics In Cancer Care Market Size, Share and Growth Outlook, 2026: Analysis By Product & Service (Consumables & Reagents, Instruments & Systems, Analytical Software & Services), By Technology (Next-Generation Sequencing , Polymerase Chain Reaction , Fluorescence In Situ Hybridization , Comparative Genomic Hybridization , Microarrays ), By Application (Cancer Diagnosis & Early Detection, Prognosis & Risk Assessment, Companion Diagnostics & Treatment Selection, Therapy Monitoring & Minimal Residual Disease ), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Hematologic , Melanoma), By Sample Type (Tissue Biopsy, Liquid Biopsy ), By End-User (Hospitals & Cancer Centers, Diagnostic & Reference Laboratories, Pharmaceutical & Biotechnology Firms, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Genomics In Cancer Care Market size is forecast to increase from $27.71 Billion in 2026 to $85.95 Billion in 2034 at a CAGR of 15.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007353
Pages: 216 Pages

Genomics Biomarkers Market Size, Share and Growth Outlook, 2026: Analysis By Biomarker Type (Predictive Biomarkers, Prognostic Biomarkers, Diagnostic Biomarkers, Surrogate Biomarkers), By Indication (Oncology , Cardiovascular Disorders, Neurological Disorders, Renal Disorders, Auto-Immune & Inflammatory Diseases), By Technology Platform (Next-Generation Sequencing , Polymerase Chain Reaction , DNA Microarrays, Mass Spectrometry), By End-User (Diagnostic Laboratories, Hospitals & Specialized Medical Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Genomics Biomarkers Market size is forecast to increase from $26.46 Billion in 2026 to $54.69 Billion in 2034 at a CAGR of 9.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007352
Pages: 226 Pages

Genome Editing Market Size, Share and Growth Outlook, 2026: Analysis By Technology (CRISPR, Zinc Finger Nucleases , Transcription Activator-Like Effector Nucleases , MegaTALs, Others), By Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Clinical, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Genome Editing Market size is forecast to increase from $9.73 Billion in 2026 to $38.87 Billion in 2034 at a CAGR of 18.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007351
Pages: 227 Pages

Genitourinary Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Disease Indication (Erectile Dysfunction, Benign Prostatic Hyperplasia , Urinary Tract Infections , Urinary Incontinence & Overactive Bladder, Prostate Cancer, Bladder, Renal Cancer), By Drug Class (Hormonal Therapy, Phosphodiesterase-5 , Alpha Blockers & 5-Alpha Reductase Inhibitors, Urinary Antispasmodics, Androgen Receptor Pathway Inhibitors, Urinary pH Modifiers), By Route of Administration (Oral, Injectable, Topical, Vaginal), By Molecule Type (Small-Molecule Drugs, Biologics & Peptides), By End User (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Genitourinary Drugs Market size is forecast to increase from $30.29 Billion in 2026 to $34.55 Billion in 2034 at a CAGR of 1.66% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007350
Pages: 221 Pages

Genital Herpes Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Infection Type (Herpes Simplex Virus-1 , Herpes Simplex Virus-2 ), By Drug Class (Nucleoside Analogues, Helicase-Primase Inhibitors, mRNA-based Therapeutics), By Drug Type (Prescription Drugs, Over-the-Counter Drugs), By Route of Administration (Oral, Injectable, Topical), By End User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Genital Herpes Treatment Market size is forecast to increase from $2.18 Billion in 2026 to $2.96 Billion in 2034 at a CAGR of 3.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007349
Pages: 210 Pages

Genetic Toxicology Testing Market Size, Share and Growth Outlook, 2026: Analysis By Test Type (In Vitro Genotoxicity Tests, In Vivo Genotoxicity Tests, In Silico ), By Component (Reagents, Kits, & Consumables, Services , Instruments & Software), By Application (Pharmaceutical & Biotechnology , Industrial Chemicals & Agrochemicals, Cosmetics & Personal-Care Products, Food Additives & Beverages), By End-User (Pharmaceutical & Biotech Manufacturers, Contract Research Organizations , Academic & Government Research Laboratories, Cosmetic & Chemical Manufacturers) Companies, and Country Forecast, 2021 to 2034

Global Genetic Toxicology Testing Market size is forecast to increase from $2.11 Billion in 2026 to $4.93 Billion in 2034 at a CAGR of 11.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007348
Pages: 220 Pages